Advertisement

Predictors of Clostridium difficile infection–related mortality among older adults

      Background

      Over 90% of annual deaths caused by Clostridium difficile infection (CDI) occur in persons aged ≥65 years. However, no large-scale studies have been conducted to investigate predictors of CDI-related mortality among older adults.

      Methods

      This case-control study included 540 CDI patients aged ≥60 years admitted to a tertiary care hospital in Detroit, Michigan, between January 2005 and December 2012. Cases were CDI patients who died within 30 days of CDI date. Controls were CDI patients who survived >30 days after CDI date. Cases were matched to controls on a 1:3 ratio based on age and hospital acquisition of CDI.

      Results

      One-hundred and thirty cases (25%) were compared with 405 controls (75%). Independent predictors of CDI-related mortality included admission from another acute hospital (odds ratio [OR], 8.25; P = .001) or a long-term care facility (OR, 13.12; P = .012), McCabe score ≥2 (OR, 12.19; P < .001), and high serum creatinine (≥1.7 mg/dL) (OR, 3.43; P = .021). The regression model was adjusted for the confounding effect of limited activity of daily living score, total number of antibiotic days prior to CDI, ileus on abdominal radiograph, low albumin (≤2.5 g/dL), elevated white blood cell count (>15 × 1,000/mm3), and admission to intensive care unit because of CDI.

      Conclusions

      Predictors of CDI-related mortality reported in this study could be applied to the development of a bedside scoring system for older adults with CDI.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Miller M.
        • Gravel D.
        • Mulvey M.
        • Taylor G.
        • Boyd D.
        • Simor A.
        • et al.
        Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
        Clin Infect Dis. 2010; 50: 194-201
        • Zar F.A.
        • Bakkanagari S.R.
        • Moorthi K.M.
        • Davis M.B.
        A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
        Clin Infect Dis. 2007; 45: 302-307
        • Bobo L.D.
        • Dubberke E.R.
        • Kollef M.
        Clostridium difficile in the ICU: the struggle continues.
        Chest. 2011; 140: 1643-1653
        • Lessa F.C.
        • Winston L.G.
        • McDonald L.C.
        • Emerging Infections Program C. difficile Surveillance Team
        Burden of Clostridium difficile infection in the United States.
        N Engl J Med. 2015; 372: 2369-2370
        • Kwon J.H.
        • Olsen M.A.
        • Dubberke E.R.
        The morbidity, mortality, and costs associated with Clostridium difficile infection.
        Infect Dis Clin North Am. 2015; 29: 123-134
        • Centers for Disease Control and Prevention (CDC)
        Vital signs: preventing Clostridium difficile infections.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 157-162
        • Mitchell B.G.
        • Gardner A.
        Mortality and Clostridium difficile infection: a review.
        Antimicrob Resist Infect Control. 2012; 1: 20
        • Huttunen R.
        • Aittoniemi J.
        Risk factors for mortality in patients with Clostridium difficile infection.
        Clin Infect Dis. 2012; 54 (author reply 1214-5): 1214
        • Kotila S.M.
        • Virolainen A.
        • Snellman M.
        • Ibrahem S.
        • Jalava J.
        • Lyytikainen O.
        Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008.
        Clin Microbiol Infect. 2011; 17: 888-893
        • McGowan A.P.
        • Lalayiannis L.C.
        • Sarma J.B.
        • Marshall B.
        • Martin K.E.
        • Welfare M.R.
        Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008.
        J Hosp Infect. 2011; 77: 11-15
        • Wilson V.
        • Cheek L.
        • Satta G.
        • Walker-Bone K.
        • Cubbon M.
        • Citron D.
        • et al.
        Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.
        Clin Infect Dis. 2010; 50: e77-81
        • Abou Chakra C.N.
        • Pepin J.
        • Sirard S.
        • Valiquette L.
        Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.
        PLoS ONE. 2014; 9: e98400
        • Cohen S.H.
        • Gerding D.N.
        • Johnson S.
        • Kelly C.P.
        • Loo V.G.
        • McDonald L.C.
        • et al.
        Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA).
        Infect Control Hosp Epidemiol. 2010; 31: 431-455
        • McDonald L.C.
        • Coignard B.
        • Dubberke E.
        • Song X.
        • Horan T.
        • Kutty P.K.
        Recommendations for surveillance of Clostridium difficile-associated disease.
        Infect Control Hosp Epidemiol. 2007; 28: 140-145
        • Katz S.
        Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living.
        J Am Geriatr Soc. 1983; 31: 721-727
        • Charlson M.
        • Szatrowski T.P.
        • Peterson J.
        • Gold J.
        Validation of a combined comorbidity index.
        J Clin Epidemiol. 1994; 47: 1245-1251
        • McCabe W.A.J.G.
        Gram negative bacteremia.
        Arch Intern Med. 1962; 110: 847-855
        • Noren T.
        • Alriksson I.
        • Andersson J.
        • Akerlund T.
        • Unemo M.
        Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard.
        J Clin Microbiol. 2011; 49: 710-711
        • Redelings M.D.
        • Sorvillo F.
        • Mascola L.
        Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.
        Emerg Infect Dis. 2007; 13: 1417-1419
        • Kim J.H.
        • Toy D.
        • Muder R.R.
        Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness.
        Infect Control Hosp Epidemiol. 2011; 32: 656-660
        • Archbald-Pannone L.R.
        • McMurry T.L.
        • Guerrant R.L.
        • Warren C.A.
        Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.
        Am J Infect Control. 2015; 43: 690-693
        • Archbald-Pannone L.R.
        • Boone J.H.
        • Carman R.J.
        • Lyerly D.M.
        • Guerrant R.L.
        Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.
        J Hosp Infect. 2014; 88: 218-221
        • Loo V.G.
        • Poirier L.
        • Miller M.A.
        • Oughton M.
        • Libman M.D.
        • Michaud S.
        • et al.
        A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
        N Engl J Med. 2005; 353: 2442-2449
        • Pepin J.
        • Valiquette L.
        • Cossette B.
        Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.
        CMAJ. 2005; 173: 1037-1042
        • Inns T.
        • Gorton R.
        • Berrington A.
        • Sails A.
        • Lamagni T.
        • Collins J.
        • et al.
        Effect of ribotype on all-cause mortality following Clostridium difficile infection.
        J Hosp Infect. 2013; 84: 235-241
        • Walker A.S.
        • Eyre D.W.
        • Wyllie D.H.
        • Dingle K.E.
        • Griffiths D.
        • Shine B.
        • et al.
        Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
        Clin Infect Dis. 2013; 56: 1589-1600
        • Claesson M.J.
        • Jeffery I.B.
        • Conde S.
        • Power S.E.
        • O'Connor E.M.
        • Cusack S.
        • et al.
        Gut microbiota composition correlates with diet and health in the elderly.
        Nature. 2012; 488: 178-184
        • Kanerva M.
        • Ollgren J.
        • Virtanen M.J.
        • Lyytikainen O.
        • Prevalence Survey Study Group
        Risk factors for death in a cohort of patients with and without healthcare-associated infections in Finnish acute care hospitals.
        J Hosp Infect. 2008; 70: 353-360
        • Fabbro-Peray P.
        • Sotto A.
        • Defez C.
        • Cazaban M.
        • Molinari L.
        • Pinede M.
        • et al.
        Mortality attributable to nosocomial infection: a cohort of patients with and without nosocomial infection in a French university hospital.
        Infect Control Hosp Epidemiol. 2007; 28: 265-272
        • Solomon K.
        • Martin A.J.
        • O'Donoghue C.
        • Chen X.
        • Fenelon L.
        • Fanning S.
        • et al.
        Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses.
        J Med Microbiol. 2013; 62: 1453-1460
        • Cloud J.
        • Noddin L.
        • Pressman A.
        • Hu M.
        • Kelly C.
        Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.
        Clin Gastroenterol Hepatol. 2009; 7 (e2): 868-873
        • Pant C.
        • Madonia P.
        • Minocha A.
        • Manas K.
        • Jordan P.
        • Bass P.
        Laboratory markers as predictors of mortality in patients with Clostridium difficile infection.
        J Investig Med. 2010; 58: 43-45
        • Kim E.S.
        • Kim Y.J.
        • Park C.W.
        • Cho K.B.
        • Jang B.K.
        • Chung W.J.
        • et al.
        Response failure to the treatment of Clostridium difficile infection and its impact on 30-day mortality.
        Hepatogastroenterology. 2013; 60: 543-548
        • High K.P.
        • Bradley S.F.
        • Gravenstein S.
        • Mehr D.R.
        • Quagliarello V.J.
        • Richards C.
        • et al.
        Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America.
        J Am Geriatr Soc. 2009; 57: 375-394
        • Amella E.J.
        Presentation of illness in older adults.
        Am J Nurs. 2004; 104 (quiz 2): 40-51
        • Dansinger M.L.
        • Johnson S.
        • Jansen P.C.
        • Opstad N.L.
        • Bettin K.M.
        • Gerding D.N.
        Protein-losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization: a prospective, case-control study.
        Clin Infect Dis. 1996; 22: 932-937
      1. American Medical Association white Paper on elderly health. Report of the Council on Scientific Affairs.
        (Arch Intern Med)1990: 2459-2472 (150)
        • Trivedi K.K.
        • Kuper K.
        Hospital antimicrobial stewardship in the nonuniversity setting.
        Infect Dis Clin North Am. 2014; 28: 281-289